0,945  0,002  Monophenol monooxygenase inhibitor
0,907  0,005  Transcription factor NF kappa B inhibitor
0,904  0,004  Antioxidant
0,892  0,003  Chemopreventive
0,859  0,003  NOS2 expression inhibitor
0,846  0,005  Caspase 9 stimulant
0,838  0,004  Free radical scavenger
0,829  0,005  Chemoprotective
0,824  0,003  Antimutagenic
0,820  0,005  CYP1A2 substrate
0,815  0,004  UGT1A9 substrate
0,814  0,013  Antiinflammatory
0,801  0,002  Melanin inhibitor
0,800  0,003  UGT1A1 substrate
0,794  0,017  Apoptosis agonist
0,778  0,003  UGT1A3 substrate
0,778  0,007  Antihypercholesterolemic
0,765  0,004  Hepatic disorders treatment
0,764  0,005  Amyloid beta aggregation inhibitor
0,771  0,022  Alpha-glucosidase inhibitor
0,736  0,003  Hepatoprotectant
0,731  0,005  UGT1A6 substrate
0,720  0,005  Caspase 3 stimulant
0,701  0,008  CYP2C19 substrate
0,695  0,003  Xanthine oxidase inhibitor
0,695  0,005  CYP2C19 inhibitor
0,693  0,005  Hypoglycemic
0,686  0,005  Apoptosis antagonist
0,693  0,015  Antidiabetic
0,693  0,015  Cyclophilin D inhibitor
0,681  0,005  UDP-glucuronosyltransferase substrate
0,681  0,004  Genotoxic
0,679  0,004  Skin whitener
0,678  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,676  0,008  Cytostatic
0,662  0,017  TNF expression inhibitor
0,646  0,005  Antihypertriglyceridemic
0,656  0,016  CYP2C9 substrate
0,648  0,008  Antiosteoporotic
0,646  0,008  AR expression inhibitor
0,642  0,005  Tumour necrosis factor alpha release inhibitor
0,636  0,008  Nitric oxide antagonist
0,646  0,019  Antileukemic
0,622  0,008  Cardioprotectant
0,623  0,012  Bone diseases treatment
0,607  0,017  Prostate cancer treatment
0,591  0,009  Antiamyloidogenic
0,591  0,014  CTGF expression inhibitor
0,584  0,026  Alzheimer's disease treatment
0,558  0,005  Sulfotransferase substrate
0,555  0,004  UGT2B1 substrate
0,565  0,015  Proliferative diseases treatment
0,571  0,024  Antibacterial
0,549  0,003  UGT2B15 substrate
0,537  0,005  Amylase inhibitor
0,564  0,032  CYP3A4 substrate
0,547  0,018  CYP2D6 substrate
0,547  0,018  Mutagenic
0,531  0,004  5 Hydroxytryptamine uptake stimulant
0,541  0,015  NOS3 expression inhibitor
0,535  0,015  Lipoxygenase inhibitor
0,519  0,004  Neurotrophic factor enhancer
0,514  0,024  Histamine release inhibitor
0,527  0,048  Antineoplastic (breast cancer)
0,516  0,037  15-Lipoxygenase inhibitor
0,491  0,014  DNA damaging
0,499  0,023  Spasmolytic
0,469  0,018  Antipyretic
0,451  0,007  Lipid peroxidase inhibitor
0,447  0,004  Cystathionine beta-synthase inhibitor
0,449  0,008  Antihypotensive
0,456  0,019  UGT2B4 substrate
0,437  0,016  Antineoplastic (osteosarcoma)
0,429  0,009  UGT2B7 substrate
0,420  0,004  Antihemorrhagic
0,427  0,019  Antihypoxic
0,447  0,040  Aldehyde oxidase inhibitor
0,408  0,004  Carbonic anhydrase III inhibitor
0,406  0,003  Creatine kinase inhibitor
0,394  0,005  Antitussive
0,419  0,034  Cytotoxic
0,418  0,033  Antineoplastic (cervical cancer)
0,418  0,033  Antineoplastic (glioma)
0,426  0,046  CYP2C9 inhibitor
0,415  0,035  ICAM1 expression inhibitor
0,379  0,004  Carbonic anhydrase VI inhibitor
0,410  0,036  Antineoplastic (pancreatic cancer)
0,375  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,374  0,004  Carbonic anhydrase XV inhibitor
0,393  0,033  Sensitization
0,419  0,061  Antineoplastic (lung cancer)
0,398  0,041  Antineoplastic (melanoma)
0,366  0,010  NOS3 expression enhancer
0,361  0,005  Gout treatment
0,375  0,019  Antihelmintic
0,357  0,003  Estrogen receptor beta agonist
0,390  0,042  Antineoplastic (brain cancer)
0,353  0,006  SULT1A3 substrate
0,358  0,014  VCAM1 expression inhibitor
0,369  0,029  Antiparasitic
0,341  0,005  Estrogen receptor beta antagonist
0,367  0,033  Antineoplastic (glioblastoma multiforme)
0,337  0,005  Estrogen agonist
0,343  0,012  Liver fibrosis treatment
0,338  0,008  Cholesterol synthesis inhibitor
0,344  0,020  Antiviral (Influenza)
0,324  0,005  Estrogen antagonist
0,324  0,005  Histidine decarboxylase inhibitor
0,323  0,005  Carbonic anhydrase XIII inhibitor
0,349  0,034  Vasodilator
0,326  0,018  Antialcoholic
0,343  0,035  Vascular (periferal) disease treatment
0,368  0,060  Antineoplastic (colorectal cancer)
0,338  0,032  Antiulcerative
0,316  0,015  Protein kinase stimulant
0,309  0,015  Diabetic nephropathy treatment
0,319  0,028  RNA-directed DNA polymerase inhibitor
0,317  0,026  P-glycoprotein inhibitor
0,347  0,058  Antineoplastic (ovarian cancer)
0,299  0,012  Nitric-oxide synthase stimulant
0,337  0,055  Metabolic disease treatment
0,344  0,062  Antineoplastic (colon cancer)
0,288  0,018  Antiviral (Influenza A)
0,294  0,025  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,274  0,005  AMP-activated protein kinase stimulant
0,275  0,007  VEGF expression inhibitor
0,298  0,031  UGT1A4 substrate
0,304  0,040  Antineoplastic (sarcoma)
0,313  0,050  Antiprotozoal (Leishmania)
0,277  0,016  Glutathione S-transferase substrate
0,307  0,047  Angiogenesis stimulant
0,313  0,057  Antidiabetic (type 2)
0,324  0,070  Vasodilator, coronary
0,270  0,017  Acetylcholinesterase inhibitor
0,264  0,021  Antidote
0,283  0,040  Antineoplastic enhancer
0,295  0,054  Antidiabetic symptomatic
0,314  0,074  Antifungal
0,258  0,018  Toxic, respiratory center
0,307  0,077  Immunostimulant
0,234  0,008  Opioid kappa receptor antagonist
0,248  0,022  Hemostatic
0,248  0,025  Topoisomerase II inhibitor
0,245  0,022  UGT2B9 substrate
0,231  0,011  Constipation treatment
0,223  0,004  Estrogen receptor alpha agonist
0,244  0,026  Tubulin antagonist
0,235  0,018  Alkylator
0,272  0,059  Antineoplastic (lymphoma)
0,296  0,083  Sodium/bile acid cotransporter inhibitor
0,236  0,028  LDLR expression enhancer
0,255  0,048  Platelet adhesion inhibitor
0,283  0,075  Lipoprotein disorders treatment
0,276  0,068  GST M1-1 substrate
0,238  0,034  Protein-tyrosine phosphatase inhibitor
0,225  0,021  DNA polymerase I inhibitor
0,208  0,007  Postmenopausal disorders treatment
0,223  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,208  0,010  Gastritis treatment
0,198  0,004  Xanthine dehydrogenase inhibitor
0,262  0,072  Antineoplastic (renal cancer)
0,209  0,020  Interleukin 4 antagonist
0,224  0,036  Antineoplastic (squamous cell carcinoma)
0,191  0,005  Carbonic anhydrase VII inhibitor
0,197  0,013  HDL-cholesterol increasing
0,258  0,074  Antineoplastic (non-small cell lung cancer)
0,230  0,047  Insulin sensitizer
0,189  0,006  Antiviral (SARS coronavirus)
0,189  0,006  Antiviral (Coronavirus)
0,267  0,086  Antineoplastic (multiple myeloma)
0,211  0,031  Antidiarrheal
0,181  0,004  Antiviral (Hepatitis A)
0,189  0,013  Antiviral (Influenza B)
0,239  0,064  Antimitotic
0,187  0,015  Breast cancer-resistant protein inhibitor
0,193  0,021  Cyclooxygenase 3 inhibitor
0,182  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,275  0,107  Antithrombotic
0,210  0,043  Antiviral (Herpes)
0,252  0,086  CYP1A2 inhibitor
0,182  0,018  Topoisomerase II alpha inhibitor
0,220  0,057  Pneumotoxic
0,173  0,011  Toll-Like receptor 4 antagonist
0,286  0,124  Immunosuppressant
0,211  0,054  Antipruritic, non-allergic
0,181  0,025  Expectorant
0,188  0,037  M18 aspartyl aminopeptidase inhibitor
0,193  0,043  UGT2B10 substrate
0,161  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,168  0,021  Antineoplastic (uterine cancer)
0,173  0,026  Antineoplastic antibiotic
0,261  0,115  Angiogenesis inhibitor
0,195  0,049  Cholinergic
0,156  0,011  Estrogen receptor alpha antagonist
0,249  0,105  Antiischemic
0,167  0,024  Mucolytic
0,186  0,044  Insulin secretagoues
0,156  0,014  SULT1E1 substrate
0,159  0,021  Beta glucuronidase inhibitor
0,238  0,100  Radioprotector
0,221  0,085  Teratogen
0,145  0,011  Aldose reductase inhibitor
0,142  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,161  0,037  Topoisomerase I inhibitor
0,145  0,023  Electron transport complex I inhibitor
0,148  0,027  Opioid antagonist
0,214  0,095  Antineoplastic (liver cancer)
0,129  0,012  Alpha tubulin antagonist
0,185  0,072  Antiviral (Hepatitis)
0,139  0,027  Uric acid excretion stimulant
0,134  0,025  Protein kinase C zeta inhibitor
0,144  0,039  SULT1A1 substrate
0,137  0,033  Multidrug resistance-associated protein 1 inhibitor
0,198  0,095  Cyclic AMP phosphodiesterase inhibitor
0,163  0,064  Interferon gamma antagonist
0,179  0,080  Carcinogenic
0,125  0,030  UGT2B11 substrate
0,120  0,026  Opioid delta receptor antagonist
0,145  0,052  Antihelmintic (Trematoda)
0,242  0,149  Stroke treatment
0,136  0,043  5-Lipoxygenase inhibitor
0,106  0,015  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,251  0,162  Antipruritic, allergic
0,111  0,022  Na+ K+ transporting ATPase inhibitor
0,108  0,020  Aromatase inhibitor
0,128  0,040  Bronchodilator
0,188  0,104  Hypolipemic
0,217  0,133  12-Lipoxygenase inhibitor
0,111  0,028  Opioid mu receptor antagonist
0,145  0,062  Antifungal enhancer
0,240  0,158  Antineoplastic (small cell lung cancer)
0,092  0,010  Opioid kappa receptor agonist
0,179  0,100  Embryotoxic
0,186  0,110  Antineoplastic (lymphocytic leukemia)
0,112  0,037  Paget's disease treatment
0,121  0,046  Butyrylcholinesterase inhibitor
0,136  0,062  Liver cirrhosis treatment
0,144  0,073  Antineoplastic (carcinoma)
0,083  0,012  Postcoital contraceptive
0,085  0,016  Fatty acid synthase inhibitor
0,097  0,029  Lipase inhibitor
0,218  0,150  CYP3A4 inhibitor
0,070  0,004  Sodium/glucose cotransporter 2 inhibitor
0,145  0,081  Peroxidase inhibitor
0,067  0,004  Sodium/glucose cotransporter inhibitor
0,178  0,116  Antiviral (HIV)
0,091  0,029  Carbonic anhydrase VA inhibitor
0,111  0,050  Dementia treatment
0,089  0,031  Carbonic anhydrase V inhibitor
0,107  0,050  Vascular dementia treatment
0,073  0,018  Antibiotic Glycopeptide-like
0,242  0,191  Antiparkinsonian
0,074  0,026  Transcription factor AP-1 inhibitor
0,151  0,103  DNA methyltransferase I inhibitor
0,051  0,004  Sodium/glucose cotransporter 1 inhibitor
0,151  0,103  Antineoplastic (gastric cancer)
0,211  0,164  Vasodilator, peripheral
0,157  0,110  Psychostimulant
0,087  0,041  Antibiotic
0,099  0,053  Alcohol dehydrogenase inhibitor
0,124  0,078  NADPH oxidase inhibitor
0,077  0,031  Beta tubulin antagonist
0,109  0,065  Chelator
0,050  0,010  Cholesterol absorption inhibitor
0,071  0,031  Nitric oxide donor
0,142  0,102  Antiviral (Hepatitis C)
0,071  0,033  Neuraminidase inhibitor
0,058  0,020  Estradiol 17 beta-dehydrogenase inhibitor
0,084  0,047  Macrophage migration inhibitory factor inhibitor
0,128  0,092  Antiischemic, cerebral
0,121  0,085  Alkaline phosphatase inhibitor
0,082  0,046  Analgesic, opioid
0,059  0,024  Opioid mu receptor agonist
0,049  0,015  Arginase inhibitor
0,062  0,028  Opioid agonist
0,069  0,037  Neuraminidase (influenza) inhibitor
0,102  0,070  Choleretic
0,088  0,057  Androgen antagonist
0,076  0,047  CDC25A inhibitor
0,107  0,079  Microtubule formation inhibitor
0,066  0,039  Transcription factor RelA inhibitor
0,111  0,084  Alcohol dehydrogenase substrate
0,120  0,094  Neurotrophic factor
0,114  0,091  Antibacterial (Helicobacter pylori)
0,054  0,031  Glucose-6-phosphate translocase inhibitor
0,036  0,016  Estrogen-related receptor beta antagonist
0,085  0,067  Actinic keratosis treatment
0,068  0,052  HIV-1 integrase inhibitor
0,074  0,058  Antitreponemal
0,039  0,023  Glucose-6-phosphate dehydrogenase inhibitor
0,074  0,059  Narcotic antagonist
0,235  0,222  Calcium channel L-type activator
0,025  0,014  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,062  0,052  Leukotriene synthesis inhibitor
0,034  0,024  Tubulin agonist
0,130  0,121  Heat shock protein 70 antagonist
0,059  0,052  Leukotriene antagonist
0,100  0,095  Antiviral (Hepatitis B)
0,096  0,093  Proteasome inhibitor
0,049  0,046  Protein kinase C eta inhibitor
0,097  0,095  Photosensitizer
0,032  0,030  Opioid delta receptor agonist
0,125  0,124  Aldose reductase substrate
0,093  0,092  DOPA decarboxylase inhibitor
0,140  0,140  Abortion inducer

